Four-Year Evolution of a Thrombophylaxis Protocol in an Enhanced Recovery After Surgery (ERAS) Program: Recent Results in 485 Patients

Obes Surg. 2018 Jul;28(7):2140-2144. doi: 10.1007/s11695-018-3299-4.

Abstract

"Enhanced recovery after surgery" (ERAS) protocols may reduce morbidity, length of hospital stay (LOS), and costs. During the 4-year evolution of a bariatric ERAS protocol, we found that administration of thrombophylaxis selectively to high-risk morbidly obese patients (assessed postoperatively by Caprini score ≥ 3) undergoing omega loop gastric bypass ("mini" gastric bypass) or sleeve gastrectomy resulted in safe outcomes. Both procedures proved equally effective with this protocol. The vast majority of rapidly mobilized, low-risk patients did not appear to require antithrombotic heparin. Similar to other reported ERAS outcomes, our recent year's results in 485 patients included a mean LOS of 1.08 ± 0.64 days (range 1-14), with 460 (95.0%) discharged on day 1 and 99.6% by day 2. There were 13 30-day complications (2.7%), two reinterventions (0.4%), and no hemorrhages.

Keywords: Bariatric; ERAS; Enhanced recovery after surgery; LSG; MGB; Omega loop; Sleeve gastrectomy.

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use*
  • Bariatric Surgery / adverse effects
  • Bariatric Surgery / methods*
  • Bariatric Surgery / rehabilitation*
  • Chemoprevention / methods
  • Chemoprevention / trends*
  • Efficiency, Organizational
  • Female
  • Follow-Up Studies
  • Humans
  • Laparoscopy / adverse effects
  • Laparoscopy / methods
  • Laparoscopy / rehabilitation
  • Length of Stay
  • Male
  • Middle Aged
  • Morbidity
  • Obesity, Morbid / drug therapy*
  • Obesity, Morbid / surgery*
  • Patient Discharge / standards
  • Patient Discharge / statistics & numerical data
  • Postoperative Complications / prevention & control
  • Postoperative Period
  • Preoperative Care / methods
  • Preoperative Care / trends*
  • Recovery Room / organization & administration
  • Recovery Room / standards
  • Thrombosis / prevention & control*
  • Time Factors
  • Treatment Outcome

Substances

  • Anticoagulants